Chrono Therapeutics Inc. is a specialty pharmaceutical and product pipeline company focused on the development, commercialization and manufacture of drug products utilizing its proprietary transdermal drug delivery platform ChronoDose™. Chrono Therapeutics, a Delaware Corporation, was founded by Guy DiPierro in 2003 as DiPierro Ventures, Inc. and changed its name to Chrono Therapeutics Inc. in 2004. In 2003, Chrono Therapeutics partnered with the University of Basel, Switzerland, and two other Swiss Universities and secured exclusive rights to intellectual property broadly protecting its field that was created by the University of Basel, including know-how, trade-secrets. Website is not available